The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Colombel, J., Sandborn, W. J., Rutgeerts, P., Enns, R., Hanauer, S. B., Panaccione, R., Schreiber, S., Byczkowski, D., Li, J., Kent, J. D., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.041 · Cited by 2,245
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,015
Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
Vande Casteele, N., Ferrante, M., Van Assche, G., Ballet, V., Compernolle, G., Van Steen, K., Simoens, S., Rutgeerts, P., Gils, A., & Vermeire, S. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.031 · Cited by 886
Self-citationColombel, J., Ferrari, N., Debuysere, H., Marteau, P., Gendre, J., Bonaz, B., Soulé, J.-C., Modigliani, R., Touze, Y., Catala, P., et al. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70354-4 · Cited by 619
Afif, W., Loftus, E. V., Faubion, W. A., Kane, S. V., Bruining, D. H., Hanson, K. A., & Sandborn, W. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.9 · Cited by 486
Dubinsky, M. C., Yang, H., Hassard, P. V., Seidman, E. G., Kam, L. Y., Abreu, M. T., Targan, S. R., & Vasiliauskas, E. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.32420 · Cited by 483
Steenholdt, C., Brynskov, J., Thomsen, O. Ø., Munck, L. K., Fallingborg, J., Christensen, L. A., Pedersen, G., Kjeldsen, J., Jacobsen, B. A., Oxholm, A. S., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305279 · Cited by 460
Brandse, J. F., van den Brink, G. R., Wildenberg, M. E., van der Kleij, D., Rispens, T., Jansen, J. M., Mathôt, R. A., Ponsioen, C. Y., Löwenberg, M., & D’Haens, G. R. A. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.016 · Cited by 433
Osterman, M. T., Kundu, R., Lichtenstein, G. R., & Lewis, J. D. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.046 · Cited by 394
Cornillie, F., Hanauer, S. B., Diamond, R. H., Wang, J., Tang, K. L., Xu, Z., Rutgeerts, P., & Vermeire, S. (2014) · Gut · doi:10.1136/gutjnl-2012-304094 · Cited by 374
Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient
Vande Casteele, N., Gils, A., Singh, S., Ohrmund, L., Hauenstein, S., Rutgeerts, P., & Vermeire, S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.12 · Cited by 346
Self-citationAdedokun, O. J., Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Xu, Z., Marano, C. W., Johanns, J., Zhou, H., Davis, H. M., Cornillie, F., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.035 · Cited by 341
Yanai, H., Lichtenstein, L., Assa, A., Mazor, Y., Weiss, B., Levine, A., Ron, Y., Kopylov, U., Bujanover, Y., Rosenbach, Y., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.07.029 · Cited by 316
Ungar, B., Chowers, Y., Yavzori, M., Picard, O., Fudim, E., Har-Noy, O., Kopylov, U., Eliakim, R., Ben-Horin, S., & on behalf of ABIRISK consortium (2014) · Gut · doi:10.1136/gutjnl-2013-305259 · Cited by 309
Cuffari, C., Hunt, S., & Bayless, T. M. (2001) · Gut · doi:10.1136/gut.48.5.642 · Cited by 306
Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases
Colombel, J.-F., Narula, N., & Peyrin-Biroulet, L. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.046 · Cited by 299
Vande Casteele, N., Khanna, R., Levesque, B. G., Stitt, L., Zou, G. Y., Singh, S., Lockton, S., Hauenstein, S., Ohrmund, L., Greenberg, G. R., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307883 · Cited by 289
Self-citationRoblin, X., Marotte, H., Rinaudo, M., Del Tedesco, E., Moreau, A., Phelip, J. M., Genin, C., Peyrin–Biroulet, L., & Paul, S. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.07.010 · Cited by 279
Gibson, D. J., Heetun, Z. S., Redmond, C. E., Nanda, K. S., Keegan, D., Byrne, K., Mulcahy, H. E., Cullen, G., & Doherty, G. A. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.07.041 · Cited by 268
Papamichael, K., Gils, A., Rutgeerts, P., Levesque, B. G., Vermeire, S., Sandborn, W. J., & Casteele, N. V. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000202 · Cited by 243
Bortlik, M., Duricova, D., Malickova, K., Machkova, N., Bouzkova, E., Hrdlicka, L., Komarek, A., & Lukas, M. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.10.019 · Cited by 232
Paul, S., Del Tedesco, E., Marotte, H., Rinaudo-Gaujous, M., Moreau, A., Phelip, J.-M., Genin, C., Peyrin-Biroulet, L., & Roblin, X. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182a77b41 · Cited by 222
Converging goals of treatment of inflammatory bowel disease from clinical trials and practice
Levesque, B. G., Sandborn, W. J., Ruel, J., Feagan, B. G., Sands, B. E., & Colombel, J.-F. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.08.003 · Cited by 217 · cited 3×
“Clinical disease activity has modest correlation with endoscopic disease activity, risk of surgery, and disease-related complications, at least in patients with CD.(34) Third, besides the mild inconvenience of blood test for TDM, there is potential misclassification and missed treatment optimization opportunities due…”
BackgroundTherapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease
Ordás, I., Feagan, B. G., & Sandborn, W. J. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.06.032 · Cited by 211
Coenen, M. J. H., de Jong, D. J., van Marrewijk, C. J., Derijks, L. J. J., Vermeulen, S. H., Wong, D. R., Klungel, O. H., Verbeek, A. L. M., Hooymans, P. M., Peters, W. H. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.002 · Cited by 199
Mazor, Y., Almog, R., Kopylov, U., Ben Hur, D., Blatt, A., Dahan, A., Waterman, M., Ben‐Horin, S., & Chowers, Y. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12869 · Cited by 189
A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis
Arias, M. T., Vande Casteele, N., Vermeire, S., de Buck van Overstraeten, A., Billiet, T., Baert, F., Wolthuis, A., Van Assche, G., Noman, M., Hoffman, I., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.07.055 · Cited by 188
Self-citationVelayos, F. S., Kahn, J. G., Sandborn, W. J., & Feagan, B. G. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.035 · Cited by 179
Steenholdt, C., Bendtzen, K., Brynskov, J., Thomsen, O. Ø., & Ainsworth, M. A. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2010.536254 · Cited by 175
Yarur, A. J., Kubiliun, M. J., Czul, F., Sussman, D. A., Quintero, M. A., Jain, A., Drake, K. A., Hauenstein, S. I., Lockton, S., Deshpande, A. R., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.12.026 · Cited by 161
Self-citationImmunogenicity of recombinant human proteins: causes and consequences
Schellekens, H., & Casadevall, N. (2004) · Journal of Neurology · doi:10.1007/s00415-004-1202-9 · Cited by 158
Association of Induction Infliximab Levels With Clinical Response in Perianal Crohn’s Disease
Davidov, Y., Ungar, B., Bar‐Yoseph, H., Carter, D., Haj-Natour, O., Yavzori, M., Chowers, Y., Eliakim, R., Ben‐Horin, S., & Kopylov, U. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw182 · Cited by 158
Implementation of TPMT testing
Lennard, L. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12226 · Cited by 157
Singh, N., Rosenthal, C. J., MELMED, G. Y., Mirocha, J., Farrior, S., Callejas, S., Tripuraneni, B., Rabizadeh, S., & Dubinsky, M. C. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000137 · Cited by 155
Bendtzen, K., Ainsworth, M. A., Steenholdt, C., Thomsen, O. Ø., & Brynskov, J. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802699278 · Cited by 151
Steenholdt, C., Ainsworth, M. A., Tovey, M. G., Klausen, T. W., Thomsen, O. Ø., Brynskov, J., & Bendtzen, K. (2013) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31828d23c3 · Cited by 124
Booth, R. A., Ansari, M., Loit, E., Tricco, A. C., Weeks, L., Doucette, S. P., Skidmore, B., Sears, M., Sy, R. G., & Karsh, J. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-12-201106210-00009 · Cited by 122
Yarur, A. J., Jain, A., Hauenstein, S. I., Quintero, M. A., Barkin, J. S., Deshpande, A. R., Sussman, D. A., Singh, S., & Abreu, M. T. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000689 · Cited by 116
Self-citationFrederiksen, M. T., Ainsworth, M. A., Brynskov, J., Thomsen, O. Ø., Bendtzen, K., & Steenholdt, C. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000138 · Cited by 115
Reinshagen, M., Schütz, E., Armstrong, V. W., Behrens, C., von Tirpitz, C., Stallmach, A., Herfarth, H. H., Stein, J. M., Bias, P., Adler, G., et al. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.086215 · Cited by 109
Self-citationSharma, S., Eckert, D., Hyams, J. S., Mensing, S., Thakkar, R. B., Robinson, A. M., Rosh, J. R., Ruemmele, F. M., & Awni, W. M. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000327 · Cited by 105
The AGA Institute Process for Developing Clinical Practice Guidelines Part One: Grading the Evidence
Sultan, S., Falck–Ytter, Y., & Inadomi, J. M. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.001 · Cited by 104 · cited 2×
“479 Quality of Evidence The GRADE approach was used to rate the quality of evidence (or confidence in summary effect estimates).(7) In this approach, direct evidence from RCTs starts at high quality and can be rated down based on risk of bias in the body of evidence (or study quality), indirectness (addressing a diffe…”
MethodSelf-citationHaines, M. L., Ajlouni, Y., Irving, P. M., Sparrow, M., Rose, R., Gearry, R. B., & Gibson, P. R. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21458 · Cited by 98
Association Between 6-Thioguanine Nucleotides Levels and Clinical Remission in Inflammatory Disease
Carla-Moreau, A., Paul, S., Tedesco, É. D., Rinaudo-Gaujous, M., Boukhadra, N., Genin, C., Peyrin‐Biroulet, L., & Roblin, X. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000439068.71126.00 · Cited by 95
Ungar, B., Mazor, Y., Weisshof, R., Yanai, H. A., Ron, Y., Goren, I., Waizbard, A., Yavzori, M., Fudim, E., Picard, O., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13631 · Cited by 91
Factors Associated With Short- and Long-Term Outcomes of Therapy for Crohn’s Disease
Reinisch, W., Colombel, J., Sandborn, W. J., Mantzaris, G. J., Kornbluth, A. A., Adedokun, O. J., Miller, M., Tang, K. L., Rutgeerts, P. J., & Cornillie, F. J. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.09.031 · Cited by 83
Thompson, A., Newman, W. G., Elliott, R. A., Roberts, S. A., Tricker, K. J., & Payne, K. (2014) · Value in Health · doi:10.1016/j.jval.2013.10.007 · Cited by 82
Randomised clinical trial: individualised vs. weight‐based dosing of azathioprine in Crohn's disease
Dassopoulos, T., Dubinsky, M. C., Bentsen, J. L., Martin, C. F., Galanko, J. A., Seidman, E. G., Sandler, R. S., & Hanauer, S. B. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12555 · Cited by 80
Newman, W. G., Payne, K., Tricker, K. J., Roberts, S. A., Fargher, E., Pushpakom, S. P., Alder, J. E., Sidgwick, G. P., Payne, D., Elliott, R. A., et al. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.32 · Cited by 75
Yarur, A. J., & Rubin, D. T. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000380 · Cited by 66
Lewis, J. D., Abramson, O., Pascua, M. F., Liu, L., Asakura, L., Velayos, F. S., Hutfless, S. M., Alison, J. E., & Herrinton, L. J. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.07.019 · Cited by 64
Wolf, D. C., D’Haens, G., Sandborn, W. J., Colombel, J. F., Assche, G. V., Robinson, A. M., Lazar, A., Zhou, Q., Petersson, J., & Thakkar, R. B. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12863 · Cited by 60
Marini, J. C., Sendecki, J. A., Cornillie, F. J., Popp, J. W., Black, S. C., BLANK, M. A., Gils, A., Stappen, T. V., Hamann, D., Rispens, T., et al. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9981-3 · Cited by 60
Smith, M. A., Blaker, P. A., Patel, C., Marinaki, A. M., Arenas, M., Escuredo, E., Anderson, S., Irving, P. M., & Sanderson, J. D. (2012) · International Journal of Clinical Practice · doi:10.1111/ijcp.12039 · Cited by 59
Sayani, F. A., Prosser, C., Bailey, R. J., Jacobs, P., & Fedorak, R. N. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/470863 · Cited by 59
Toxicity and response to thiopurines in patients with inflammatory bowel disease
Goldberg, R., & Irving, P. M. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1039987 · Cited by 46
van Asseldonk, D. P., Sanderson, J. D., de Boer, N. K. H., Sparrow, M., Lémann, M., Ansari, A. R., Almer, S. H., Florin, T. H., Gearry, R. B., Mulder, C. J. J., et al. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.09.001 · Cited by 46
Pavlidis, P., Stamoulos, P., Abdulrehman, A., Kerr, P., Bull, C., Duley, J. A., & Ansari, A. R. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000827 · Cited by 42
Mottet, C., Schoepfer, A. M., Juillerat, P., Cosnes, J., Froehlich, F., Brondolo, V. K., Seibold, F., Rogler, G., Vavricka, S. R., & Michetti, P. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000923 · Cited by 39
Steenholdt, C., Frederiksen, M. T., Bendtzen, K., Ainsworth, M. A., Thomsen, O. Ø., & Brynskov, J. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000375 · Cited by 22
Significance of low level infliximab in the absence of anti-infliximab antibodies
Ungar, B. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i6.1907 · Cited by 19
Roy, L. M., Zur, R. M., Uleryk, E. M., Carew, C., Ito, S., & Ungar, W. J. (2016) · Pharmacogenomics · doi:10.2217/pgs.16.12 · Cited by 18
Cited by
ACG Clinical Guideline: Management of Crohn's Disease in Adults
Lichtenstein, G. R., Loftus, E. V., Isaacs, K. L., Regueiro, M. D., Gerson, L. B., & Sands, B. E. (2018) · American Journal of Gastroenterology · doi:10.1038/ajg.2018.27 · Cited by 1,421
Kennedy, N. A., Heap, G. A., Green, H. D., Hamilton, B., Bewshea, C., Walker, G. J., Thomas, A., Nice, R., Perry, M. H., Bouri, S., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30012-3 · Cited by 691
Self-citationFeuerstein, J. D., Nguyen, G. C., Kupfer, S. S., Falck-Ytter, Y., Singh, S., Gerson, L., Hirano, I., Nguyen, G. C., Rubenstein, J. H., Smalley, W. E., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.07.032 · Cited by 576
Self-citationFeuerstein, J. D., Ho, E. Y., Shmidt, E., Singh, H., Falck-Ytter, Y., Sultan, S., Terdiman, J. P., Sultan, S., Cohen, B. L., Chachu, K., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.04.022 · Cited by 407
Self-citationFeuerstein, J. D., Moss, A. C., & Farraye, F. A. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.01.018 · Cited by 398
Metadata
- Authors
- Vande Casteele, N., Herfarth, H., Katz, J., Falck-Ytter, Y., & Singh, S.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 153
- Issue
- 3
- Pages
- 835-857.e6
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2741466972
- Cited by
- 295
- References
- 66
- FWCI
- 24.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.